AbbVie
ABBV
#26
Rank
HK$3.110 T
Marketcap
HK$1,760
Share price
-1.15%
Change (1 day)
31.91%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of September 2025 : HK$1.042 Trillion

According to AbbVie's latest financial reports the company's total assets are HK$1.042 Trillion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$1.049 T-0.26%
2023-12-31HK$1.052 T-2.99%
2022-12-31HK$1.084 T-5.08%
2021-12-31HK$1.142 T-2.11%
2020-12-31HK$1.167 T68.18%
2019-12-31HK$694.03 B49.33%
2018-12-31HK$464.77 B-15.96%
2017-12-31HK$553.04 B7.9%
2016-12-31HK$512.56 B24.66%
2015-12-31HK$411.17 B92.67%
2014-12-31HK$213.40 B-5.75%
2013-12-31HK$226.41 B8.15%
2012-12-31HK$209.34 B38.07%
2011-12-31HK$151.61 B-7.82%
2010-12-31HK$164.47 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
HK$1.624 T 55.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$754.24 B-27.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$894.72 B-14.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$701.71 B-32.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$455.65 B-56.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$227.36 B-78.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$641.92 B-38.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
HK$890.99 B-14.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$33.20 B-96.81%๐Ÿ‡บ๐Ÿ‡ธ USA